Antimicrobial Drugs and Mechanisms

Core Explanation

Selective toxicity — the guiding principle. A good antimicrobial has selective toxicity: it harms the microbe but not the human host. This is achieved by targeting structures or processes that the microbe has and human cells lack (or that differ) — recall the prokaryote–eukaryote differences. This is why antibacterial drugs (targeting bacteria-specific features like the peptidoglycan wall) can be very safe, while drugs against fungi, protozoa, and viruses (which are more similar to us or hide inside our cells) tend to be harder to make selectively toxic and may have more side effects.

Mechanisms of antibacterial drugs. Antibiotics work by attacking essential bacterial structures or processes (recall these from earlier units):

• Inhibit cell wall synthesis: block peptidoglycan production so the wall weakens and the bacterium bursts (e.g., penicillins). Very selective, since human cells have no cell wall.
• Inhibit protein synthesis: target the bacterial ribosome (different from ours), stopping protein production.
• Inhibit nucleic acid synthesis: block bacterial DNA replication or transcription.
• Inhibit metabolic pathways: block a bacterial metabolic step humans don't use (or get differently).
• Disrupt the cell membrane: damage the bacterial membrane.

Drugs may be bactericidal (kill bacteria) or bacteriostatic (stop them from multiplying, letting the immune system clear them).

Broad- vs narrow-spectrum. Antimicrobials differ in how many types of microbes they affect:

• Broad-spectrum drugs act against a wide range of bacteria (both Gram-positive and Gram-negative). Useful when the pathogen is unknown, but they also kill more normal microbiota, which can cause side effects (like diarrhea or yeast overgrowth) and promote resistance.
• Narrow-spectrum drugs target a specific group of bacteria. Preferred when the pathogen is identified (via culture and sensitivity), because they spare normal microbiota and reduce resistance pressure.

Drugs for other microbes. Different microbe groups need different drugs (recall the overview): antibacterials (bacteria), antifungals (fungi), antivirals (viruses — which, being intracellular non-living particles, are especially challenging), and antiparasitics (protozoa, helminths). Matching the drug to the microbe group is fundamental — and again, antibiotics don't work on viruses.

How It Works

Antimicrobial action:

Selective toxicity: target microbe-specific features (spare human cells)
Antibacterial mechanisms: block cell wall | protein synthesis (ribosome) | nucleic acid synthesis | metabolism | membrane
Bactericidal (kill) vs bacteriostatic (stop multiplying)
Spectrum: broad (wide range, more microbiota disruption) vs narrow (targeted, preferred when pathogen known)
Match group: antibacterial / antifungal / antiviral / antiparasitic

Important Relationships and Comparisons

High-Yield Pre-Nursing Connections

Nurses administer antimicrobials and monitor for effectiveness and side effects (like allergic reactions to penicillins, or antibiotic-associated diarrhea/C. difficile from disrupting normal microbiota). Culture and sensitivity results guide switching from broad- to narrow-spectrum therapy — good stewardship. Knowing that antibiotics don't treat viral infections prevents misuse. Understanding selective toxicity explains why some antimicrobials are safer than others.

Common Confusions

• Bactericidal (kills) vs bacteriostatic (stops growth).
• Broad-spectrum vs narrow-spectrum — wide coverage vs targeted (narrow preferred when the pathogen is known).
• Selective toxicity relies on microbe–human differences (harder for fungi/protozoa/viruses).
• Antibiotics ≠ antivirals — match the drug to the microbe group.

Memory Aids

• "Selective toxicity = hit the germ, spare the host."
• Mechanisms: "Wall, Protein, Nucleic acid, Metabolism, Membrane."
• "Broad = big net (more side effects); Narrow = targeted."

Quick Recap

• Selective toxicity: antimicrobials target microbe-specific features to harm the germ but spare the host (easiest for antibacterials; harder for antifungals/antivirals).
• Antibacterial mechanisms: block cell wall synthesis, protein synthesis (ribosome), nucleic acid synthesis, metabolism, or the membrane; drugs are bactericidal or bacteriostatic.
• Broad-spectrum (wide range, more microbiota disruption) vs narrow-spectrum (targeted, preferred when the pathogen is known).
• Match the drug to the microbe group (antibacterial/antifungal/antiviral/antiparasitic); antibiotics don't treat viruses.

Key terms

Key terms are emphasized and defined within the main notes.

Important formulas or processes

See the formulas, procedures, and process blocks in the main notes where applicable.

Common mistakes

See the labeled common-mistake callouts in the main notes where present.